BACKGROUND: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution therapy (OST), HIV counselling and testing, HIV antiretroviral therapy (ART), and condom distribution programmes. We aimed to produce country-level, regional, and global estimates of coverage of NSP, OST, HIV testing, ART, and condom programmes for PWID. METHODS: We completed searches of peer-reviewed (MEDLINE, Embase, and PsycINFO), internet, and grey literature databases, and disseminated data requests via social media and targeted emails to international experts. Programme and survey data on each of t...
Background People who inject drugs (PWID) are at elevated risk of HIV infection. Data on population ...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepat...
Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepat...
Summary: Background: People who inject drugs (PWID) are a key population affected by the global HIV...
© 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-N...
Background: Previous reviews have examined the existence of HIV prevention, treatment, and care ser...
AbstractPeople who inject drugs (PWID) are at an elevated risk of infection by human immunodeficienc...
Summary: Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause ...
Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease...
BACKGROUND: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease...
Background: Harm reduction and treatment programs are essential for reducing harms experienced by pe...
BACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV an...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Background People who inject drugs (PWID) are at elevated risk of HIV infection. Data on population ...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepat...
Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepat...
Summary: Background: People who inject drugs (PWID) are a key population affected by the global HIV...
© 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-N...
Background: Previous reviews have examined the existence of HIV prevention, treatment, and care ser...
AbstractPeople who inject drugs (PWID) are at an elevated risk of infection by human immunodeficienc...
Summary: Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause ...
Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease...
BACKGROUND: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease...
Background: Harm reduction and treatment programs are essential for reducing harms experienced by pe...
BACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV an...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Background People who inject drugs (PWID) are at elevated risk of HIV infection. Data on population ...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...